Supernus Pharmaceuticals (SUPN) Cash from Operations Growth (1y) (2012 - 2026)
Supernus Pharmaceuticals (SUPN) Cash from Operations Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 61.90% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -22.14% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 0.46% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 125.00% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 425.00% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -267.74% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -18.09% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.33% |
| 10 | Supernus Pharmaceuticals | 2.63 Bn | 2.24 Bn | - | 117.41% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 117.41% |
| Dec 31, 2025 | -55.27% |
| Sep 30, 2025 | -215.22% |
| Jun 30, 2025 | 64.31% |
| Mar 31, 2025 | -20.32% |
| Dec 31, 2024 | -1.23% |
| Sep 30, 2024 | 49.18% |
| Jun 30, 2024 | 288.75% |
| Mar 31, 2024 | -21.83% |
| Dec 31, 2023 | 63.10% |
| Sep 30, 2023 | 159.19% |
| Jun 30, 2023 | -126.54% |
| Mar 31, 2023 | 1,041.93% |
| Dec 31, 2022 | -43.47% |
| Sep 30, 2022 | 436.76% |
| Jun 30, 2022 | 53.69% |
| Mar 31, 2022 | -88.12% |
| Dec 31, 2021 | 52.70% |
| Sep 30, 2021 | -173.41% |
| Jun 30, 2021 | -49.68% |